c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Opaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock
Investing.com | Nov 5, 2026 9:31 PM EST
Read original article